Clinical and Financial Implications of Inpatient and Outpatient Management of Worsening Heart Failure
In this nationwide analysis of older US adults, high rates of death and substantial reductions in home-time occurred following WHF regardless of inpatient or outpatient management, but were worse following HF hospitalization. Outpatient IV diuretic administration was the least expensive initial management strategy, but over the subsequent 12 months, associated costs were similar or higher than costs following HF hospitalization.
Authors
- Karen Chiswell (ORCID: https://orcid.org/0000-0002-0279-9093)
- Adrian F. Hernandez (ORCID: https://orcid.org/0000-0003-3387-9616)
- Lisa A. Kaltenbach
- G. Michael Felker (ORCID: https://orcid.org/0000-0002-5931-1239)
- Hubert B. Haywood (ORCID: https://orcid.org/0000-0002-3566-9578)
- Muhammad Shahzeb Khan (ORCID: https://orcid.org/0000-0003-1250-6351)
- Bradley G. Hammill (ORCID: https://orcid.org/0000-0002-0389-6434)
- Gregg C. Fonarow (ORCID: https://orcid.org/0000-0002-3192-8093)
- Veraprapas Kittipibul (ORCID: https://orcid.org/0000-0002-9107-1837)
- Javed Butler (ORCID: https://orcid.org/0000-0003-4267-6933)
- Stephen J. Greene
Institutions
- University of California, Los Angeles (US)
- Duke University (US)
- University of Mississippi (US)
- Clinical Research Institute (US)
- Baylor Medical Center at Garland (US)
Publication Details
- Journal
- European Journal of Heart Failure
- Published
- 2025-05-26
- DOI
- https://doi.org/10.1002/ejhf.3702
- Citations
- 2
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.78
Funders
- American Heart Association
- Boehringer Ingelheim España
- Novo Nordisk